Skip to content

Effect of Propolis gel versus placebo on wound treatment in patients with recurrent minor aphtous ulceration

Effect of Propolis gel versus placebo on wound treatment in patients with recurrent minor aphtous ulceration: a double-blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201411269014N49
Enrollment
50
Registered
2014-12-02
Start date
2014-11-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aphtous ulcers. Recurrent oral aphthae

Interventions

Intervention 1: putting 1 cm in length of Propolis gel on aphtous ulcers 4 time a day for 6 days. Intervention 2: putting 1 cm in length of orabase gel (placebo) on aphtous ulcers 4 time a day for 6 d
Treatment - Drugs
Placebo
putting 1 cm in length of Propolis gel on aphtous ulcers 4 time a day for 6 days
putting 1 cm in length of orabase gel (placebo) on aphtous ulcers 4 time a day for 6 days

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) age of 15 to 60 years; (b) having recurrent minor aphtous ulcers; (c) history of disease for more than one year with at least two recurrence a year; (d) having 1 to 6 ulceration if each episode; (e) less than 72 hours from the begging of the ulceration; (f) the duration of healing without medication is not more than 7 days; (g) the size of ulcers is not more than 1 cm. Exclusion criteria: (a) hypersensitivity to drug or plant; (b) treatment with immunosuppressive drugs during the last month; (c) using systemic antibiotic during the last two weeks; (d) using anti-inflammatory drugs or anti-histamine during the last month; (e) using any drug for treatment of aphtous ulcers during the last 72 hours; (f) having systemic diseases such as endocrine, immunologic, hematologic, metabolic, rheumatoid arteritis, and hormonal disorders; (g) during pregnancy or breastfeeding; complete or partial denture or unsuitable restoration of a tooth or appliance ortodency in close contact with aphtous ulcers; (h) cigarette smoking or drinking alcohol; (i) affected with major aphtous ulcers or herpetiform ulcers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
Presence of erythema or exudates. Timepoint: 3 and 6 days after treatment. Method of measurement: by physical examination.

Primary

MeasureTime frame
Measuring the diameter of lesions. Timepoint: before and 3 and 6 days after treatment. Method of measurement: by physical examination.;Measuring the pain severity. Timepoint: before and 3 and 6 days after treatment. Method of measurement: by taking history.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAzadeh Moslemkhani

Dentistry School

freebird_a90@yahoo.com+98 81 3838 1086

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026